Related Experiment Videos
Advances in implantable cardioverter defibrillators
Craig Swygman1, Paul J Wang, Mark S Link
1New England Medical Center, Boston, Massachusetts, USA.
Current Opinion in Cardiology
|January 16, 2002
Summary
Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death from ventricular arrhythmias. Technological advancements have improved ICDs, expanding their use and enhancing patient outcomes.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Devices
Background:
- Implantable cardioverter defibrillators (ICDs) are vital for patients with cardiac arrest or risk of ventricular arrhythmias.
- Clinical trials validate ICD use for sustained ventricular arrhythmias and expanded indications.
Purpose of the Study:
- To review the evolution and current status of implantable cardioverter defibrillators.
- To highlight technological advancements and future directions in ICD therapy.
Main Methods:
- Review of clinical trials and technological advancements in ICDs.
- Analysis of expanded indications and device functionalities.
Main Results:
- ICDs are effective for various arrhythmias, including those in coronary artery disease and heart failure.
- Technological progress has led to smaller, more functional devices with improved arrhythmia detection.
- Biventricular pacing integrated with ICDs benefits heart failure patients.
Conclusions:
- ICDs are a cornerstone therapy for preventing sudden cardiac death.
- Ongoing technological innovation promises further improvements in ICD efficacy and patient care.
- Future ICDs will feature enhanced arrhythmia classification, automation, and biventricular pacing.